IDNA Fees and Costs — iShares Genomics Immunology and Healthcare ETF
Data updated: 2026-10-13
The net expense ratio is 0.47%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $54K in broker commissions, 0.0371% of average net assets, and portfolio turnover was 49%.
IDNA Fees and Expenses
Annual operating expenses and sales charges of IDNA. Prospectus, as of July 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.47% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.47% |
| Fee waiver | — |
| Net expense ratio | 0.47% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
IDNA Costs Over Time
On $10,000 invested in IDNA, assuming 5% a year before costs, total costs come to $320 over 5 years, cutting the return by 0.53% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.47%) | $49 | $155 | $270 |
| Trading costs (broker commissions) | $4 | $12 | $21 |
| Lost growth on money paid in costs | $0 | $8 | $29 |
| Total costs | $53 | $175 | $320 |
| Value after costs | $10,447 | $11,401 | $12,442 |
| Impact on return, per year | 0.53% | 0.53% | 0.53% |
IDNA Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0371%
- Total broker commissions: $54K
- Bought from dealers (principal trades, not a cost): $65.5M
- Portfolio turnover (prospectus): 49%
IDNA Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BNP Paribas Securities Corp. | $22K | 43.32% |
| Goldman Sachs & Co. LLC | $8K | 16.22% |
| CastleOak Securities, L.P. | $5K | 9.01% |
| Cantor Fitzgerald & Co. | $4K | 7.94% |
| Piper Sandler & Co. | $3K | 6.77% |
| Wells Fargo Securities, LLC | $3K | 5.61% |
| BofA Securities, Inc. | $3K | 5.18% |
| Samuel A. Ramirez & Company, Inc. | $1K | 2.46% |
| Citigroup Global Markets Inc. | $992 | 1.96% |
| Instinet, LLC | $786 | 1.55% |
IDNA Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BlackRock Funds III - BlackRock Cash Funds: Treasury | $21.5M | 32.85% |
| Jane Street Capital, LLC | $19.3M | 29.48% |
| J.P. Morgan Securities LLC | $16.5M | 25.17% |
| UBS Securities LLC | $4.9M | 7.50% |
| Goldman Sachs & Co. LLC | $3.3M | 5.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.